Literature DB >> 21832088

Phospholamban binds with differential affinity to calcium pump conformers.

Philip Bidwell1, Daniel J Blackwell, Zhanjia Hou, Aleksey V Zima, Seth L Robia.   

Abstract

To investigate the mechanism of regulation of sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) by phospholamban (PLB), we expressed Cerulean-SERCA and yellow fluorescent protein (YFP)-PLB in adult rabbit ventricular myocytes using adenovirus vectors. SERCA and PLB were localized in the sarcoplasmic reticulum and were mobile over multiple sarcomeres on a timescale of tens of seconds. We also observed robust fluorescence resonance energy transfer (FRET) from Cerulean-SERCA to YFP-PLB. Electrical pacing of cardiac myocytes elicited cytoplasmic Ca(2+) elevations, but these increases in Ca(2+) produced only modest changes in SERCA-PLB FRET. The data suggest that the regulatory complex is not disrupted by elevations of cytosolic calcium during cardiac contraction (systole). This conclusion was also supported by parallel experiments in heterologous cells, which showed that FRET was reduced but not abolished by calcium. Thapsigargin also elicited a small decrease in PLB-SERCA binding affinity. We propose that PLB is not displaced from SERCA by high calcium during systole, and relief of functional inhibition does not require dissociation of the regulatory complex. The observed modest reduction in the affinity of the PLB-SERCA complex with Ca(2+) or thapsigargin suggests that the binding interface is altered by SERCA conformational changes. The results are consistent with multiple modes of PLB binding or alternative binding sites.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832088      PMCID: PMC3186385          DOI: 10.1074/jbc.M111.266759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution.

Authors:  C Toyoshima; M Nakasako; H Nomura; H Ogawa
Journal:  Nature       Date:  2000-06-08       Impact factor: 49.962

2.  Photobleaching-corrected FRET efficiency imaging of live cells.

Authors:  Tomasz Zal; Nicholas R J Gascoigne
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

3.  Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition.

Authors:  Jinhui Li; Diana J Bigelow; Thomas C Squier
Journal:  Biochemistry       Date:  2004-04-06       Impact factor: 3.162

4.  Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer.

Authors:  Zhanjia Hou; Seth L Robia
Journal:  J Mol Biol       Date:  2010-07-17       Impact factor: 5.469

5.  Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.

Authors:  Zhanjia Hou; Eileen M Kelly; Seth L Robia
Journal:  J Biol Chem       Date:  2008-08-16       Impact factor: 5.157

6.  Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca(2+)-ATPase complex.

Authors:  N J Traaseth; D D Thomas; G Veglia
Journal:  J Mol Biol       Date:  2006-03-07       Impact factor: 5.469

7.  Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase.

Authors:  Qiujing Song; Sandeep Pallikkuth; Julie Bossuyt; Donald M Bers; Seth L Robia
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

8.  Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure.

Authors:  Timothy L Domeier; Lothar A Blatter; Aleksey V Zima
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

9.  Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain.

Authors:  Zhenhui Chen; Brandy L Akin; David L Stokes; Larry R Jones
Journal:  J Biol Chem       Date:  2006-03-22       Impact factor: 5.157

10.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.

Authors:  G Hasenfuss; H Reinecke; R Studer; M Meyer; B Pieske; J Holtz; C Holubarsch; H Posival; H Just; H Drexler
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

View more
  39 in total

1.  Phospholamban mutants compete with wild type for SERCA binding in living cells.

Authors:  Simon J Gruber; Suzanne Haydon; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2012-03-01       Impact factor: 3.575

2.  Characterizing phospholamban to sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking.

Authors:  Brandy L Akin; Larry R Jones
Journal:  J Biol Chem       Date:  2012-01-14       Impact factor: 5.157

3.  The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.

Authors:  Brandy L Akin; Thomas D Hurley; Zhenhui Chen; Larry R Jones
Journal:  J Biol Chem       Date:  2013-08-31       Impact factor: 5.157

4.  Thermodynamics of Cation Binding to the Sarcoendoplasmic Reticulum Calcium ATPase Pump and Impacts on Enzyme Function.

Authors:  Bin Sun; Bradley D Stewart; Amir N Kucharski; Peter M Kekenes-Huskey
Journal:  J Chem Theory Comput       Date:  2019-03-13       Impact factor: 6.006

5.  Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase.

Authors:  Sandeep Pallikkuth; Daniel J Blackwell; Zhihong Hu; Zhanjia Hou; Dane T Zieman; Bengt Svensson; David D Thomas; Seth L Robia
Journal:  Biophys J       Date:  2013-10-15       Impact factor: 4.033

6.  Atomic-level mechanisms for phospholamban regulation of the calcium pump.

Authors:  L Michel Espinoza-Fonseca; Joseph M Autry; G Lizbeth Ramírez-Salinas; David D Thomas
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

7.  Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.

Authors:  Neha Abrol; Pieter P de Tombe; Seth L Robia
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

8.  Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy.

Authors:  Delaine K Ceholski; Catharine A Trieber; Howard S Young
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

9.  Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation.

Authors:  Xiaoqiong Dong; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2014-05-09       Impact factor: 3.575

10.  Crystal structures of the calcium pump and sarcolipin in the Mg2+-bound E1 state.

Authors:  Chikashi Toyoshima; Shiho Iwasawa; Haruo Ogawa; Ayami Hirata; Junko Tsueda; Giuseppe Inesi
Journal:  Nature       Date:  2013-03-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.